Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Wheeler

Showing results (331-340 of 455) with videos related to

Pageof 46
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 24, 2006
The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKDMartin Landray, Colin Baigent, Craig Leaper, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 24, 2021
Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE TrialHiddo J L Heerspink, Megumi Oshima, Hong Zhang, et al.
NEJM Evidence|February 6, 2024
Dapagliflozin and Anemia in Patients with Chronic Kidney DiseaseAkihiko Koshino, Meir Schechter, Glenn M Chertow, et al.
BMJ Open|April 27, 2026
Delphi approach to prioritising research in cardiovascular and kidney disease using routinely collected dataRoss Alexander Forsyth, Amy Coombe, Nigel Brunskill, et al.
European Heart Journal|March 20, 2018
Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysisCsaba P Kovesdy, Kunihiro Matsushita, Yingying Sang, et al.
European Heart Journal|March 10, 2018
Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceMintu P Turakhia, Peter J Blankestijn, Juan-Jesus Carrero, et al.
Kidney International|April 24, 2019
Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceAlfred K Cheung, Tara I Chang, William C Cushman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 8, 2016
Establishing Core Outcome Domains in Hemodialysis: Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus WorkshopAllison Tong, Braden Manns, Brenda Hemmelgarn, et al.
Kidney International Reports|September 12, 2022
Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of UtilityGlen James, Juan Jose Garcia Sanchez, Juan Jesus Carrero, et al.
JACC. Heart Failure|June 13, 2021
Heart Failure Hospitalization in Adults Receiving Hemodialysis and the Effect of Intravenous Iron TherapyPardeep S Jhund, Mark C Petrie, Michele Robertson, et al.
Pageof 46

Showing results (331-340 of 455) with videos related to

Sort By:
Pageof 46
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 24, 2006
The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKDMartin Landray, Colin Baigent, Craig Leaper, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 24, 2021
Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE TrialHiddo J L Heerspink, Megumi Oshima, Hong Zhang, et al.
NEJM Evidence|February 6, 2024
Dapagliflozin and Anemia in Patients with Chronic Kidney DiseaseAkihiko Koshino, Meir Schechter, Glenn M Chertow, et al.
BMJ Open|April 27, 2026
Delphi approach to prioritising research in cardiovascular and kidney disease using routinely collected dataRoss Alexander Forsyth, Amy Coombe, Nigel Brunskill, et al.
European Heart Journal|March 20, 2018
Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysisCsaba P Kovesdy, Kunihiro Matsushita, Yingying Sang, et al.
European Heart Journal|March 10, 2018
Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceMintu P Turakhia, Peter J Blankestijn, Juan-Jesus Carrero, et al.
Kidney International|April 24, 2019
Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceAlfred K Cheung, Tara I Chang, William C Cushman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 8, 2016
Establishing Core Outcome Domains in Hemodialysis: Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus WorkshopAllison Tong, Braden Manns, Brenda Hemmelgarn, et al.
Kidney International Reports|September 12, 2022
Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of UtilityGlen James, Juan Jose Garcia Sanchez, Juan Jesus Carrero, et al.
JACC. Heart Failure|June 13, 2021
Heart Failure Hospitalization in Adults Receiving Hemodialysis and the Effect of Intravenous Iron TherapyPardeep S Jhund, Mark C Petrie, Michele Robertson, et al.
Pageof 46